India, Sept. 18 -- The Government of India has issued a release:
The Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, along with the National Pharmaceutical Pricing Authority (NPPA), seven National Institutes of Pharmaceutical Education and Research (NIPERs), Pharmaceutical & Medical Devices Bureau of India (PMBI) and Public Sector Undertakings (PSUs) - Bengal Chemical & Pharmaceutical Ltd. (BCPL), Hindustan Antibiotics Limited (HAL), and Karnataka Antibiotics And Pharmaceuticals Ltd. (KAPL) - will actively participate in Special Campaign 6.0 from 2nd October to 31st October 2026. The initiative aims to institutionalize Swachhata culture and streamline government functioning by eliminating office pendency.
The campaign is structured in two operational phases:
Focus Areas for Special Campaign 6.0 :
Through these measures, the Department of Pharmaceuticals reaffirms its commitment to transparent governance, efficient public service delivery and sustainable office management.
Disclaimer: Curated by HT Syndication.